COMMUNIQUÉS West-GlobeNewswire

Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference
29/05/2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for [...]
Septerna to Present at Jefferies Global Healthcare Conference
29/05/2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that Jeffrey [...]
Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
29/05/2025
DUBLIN, Ireland, May 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management [...]
Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
29/05/2025
THE WOODLANDS, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2025 Jefferies Global Healthcare [...]
Digital Landia, LLC, in Cooperation with PetVivo Holdings, Inc., Announces Invite-Only MVP Availability Amid Stress-Testing & Debugging Phase
29/05/2025
MIAMI, FL, May 29, 2025 (GLOBE NEWSWIRE) -- Digital Landia, LLC (“Digital Landia”), owner of Agentic.Pet, an autonomous pet artificial intelligence ecosystem, in cooperation with PetVivo Holdings, Inc. (OTCQB: PETV; [...]
Axsome Therapeutics to Participate in Upcoming Investor Conferences
29/05/2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will [...]
Syndax Announces Participation in June Investor Conferences
29/05/2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief [...]
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
29/05/2025
WATERTOWN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference
29/05/2025
NEW YORK and WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]
Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring
29/05/2025
Discontinues Development of Cibotercept in PAH Announces Corporate Restructuring to Align Operations with Ongoing Strategic Priorities LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros [...]
A Destructive Form of Cell Death Might Be The Key To Slowing The Human Aging Process
29/05/2025
Experts across scientific and clinical fields, writing in Nature Oncogene, explore the emerging role of necrosis in aging—pointing to its potential to reshape how we understand and treat age-related conditions CAMBRIDGE [...]
Canadian Red Cross supporting people impacted by Manitoba wildfires
29/05/2025
Registration Services Opened and Appeal Launched OTTAWA, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross is currently working alongside Indigenous community leadership and all levels of government to [...]
La Croix-Rouge canadienne vient en aide aux personnes touchées par les feux de forêt au Manitoba
29/05/2025
Service d’inscription offert et appel de fonds lancé OTTAWA, Ontario, 29 mai 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne collabore présentement avec les autorités dirigeantes des communautés autochtones et tous [...]
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
29/05/2025
DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
29/05/2025
Tokyo, Japan and Cambridge, UK, 29 May 202 5 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new positive data from the Phase 2 study [...]
CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO)
29/05/2025
Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig") and Streamex Exchange Corporation ("Streamex"), collectively referred to as the combined company, [...]
Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
29/05/2025
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“ Rakovina ” or the “ Company ”) announces that in accordance with the terms of an indenture entered into [...]
Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress
28/05/2025
Oral presentation of clinical data from FT819 Phase 1 study highlights safety and efficacy of fludarabine-free treatment paradigm in moderate-to-severe systemic lupus erythematosus (SLE) SAN DIEGO, May 28, 2025 (GLOBE [...]
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
28/05/2025
• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2 nd • Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral [...]

Pages